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Abstract
Medical toxicology is the clinical specialty that
treats the toxic effects of substances, be it an
overdose, a medication error, or a scorpion sting.
The volume of toxicological knowledge has, as with
other medical specialties, outstripped the ability of
the individual clinician to master and stay current
with it.
The application of machine learning
techniques to medical toxicology is challenging
because initial treatment decisions are often based
on a few pieces of textual data and rely heavily
on prior knowledge. Moreover, ML techniques
often do not represent knowledge in a way that
is transparent for the physician, raising barriers
to usability. Rule-based systems and decision tree
learning are more transparent approaches, but often
generalize poorly and require expert curation to
implement and maintain. Here, we construct a
probabilistic logic network to represent a portion
of the knowledge base of a medical toxicologist.
Our approach transparently mimics the knowledge
representation and clinical decision-making of
practicing clinicians. The software, dubbed Tak,
performs comparably to humans on straightforward
cases and intermediate difficulty cases, but is
outperformed by humans on challenging clinical
cases. Tak outperforms a decision tree classifier at
all levels of difficulty. Probabilistic logic provides
one form of explainable artificial intelligence that
may be more acceptable for use in healthcare, if it
can achieve acceptable levels of performance.

1.

Introduction

The scope of biomedical knowledge is too vast
and rate of increase of that knowledge too rapid
for an individual physician to bring all relevant
knowledge to bear on the diagnosis and treatment
of an illness.
Machine learning and artificial
intelligence (ML/AI) approaches, trained on data
sets larger than any physician could encounter
in training, can outperform physicians on specific
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tasks, such as predicting the likelihood of response
to a chemotherapeutic treatment [1] or diagnosing
pneumonia from a chest X-ray [2]. They perform
much worse than physicians in poorly-defined tasks
such as constructing the differential diagnosis, a list
of diagnoses ranked by the likelihood of explaining
a patient’s current condition.
A barrier to integrating ML/AI into healthcare
is the difference between how ML/AI and physicians
arrive at a diagnosis.
Many current ML/AI
approaches look for quantitative patterns across
large data sets, but ignore prior knowledge
and cannot explain their reasoning in terms
of biomedical knowledge.
Pretrained models
and transfer learning incorporate statistical
relationships from prior data, but do not explicitly
represent those relationships in terms that
domain experts can readily interpret. Humans
frequently use symbolic reasoning to describe
complex systems, but ML/AI approaches rarely
do. Reliability plots and counterfactual reasoning
can explain algorithms that classify pictures of
biopsies [3], but it is not clear how these approaches
could apply to textual data. Probabilistic logic
provides a way to combine statistical learning with
symbolic reasoning, to combine machine capacity
with human intuition. Our goal was to develop an
approach whose ratiocination was transparent to
physicians, the intended user.
The organization of this paper is as follows.
Section 1 presents a primer of the relevant clinical
concepts (Section 1.1), literature review (Section
1.2), a description of probabilistic logic networks
(Section 1.3), and alternative approaches that
have been used in medical diagnosis (Section
1.4). Section 2 describes the construction of our
probabilistic logic network. Section 3 presents the
results, and Section 4 the conclusions.

1.1.

The Diagnosis and Treatment of a
Poisoned Patient

The goal of this section is to briefly describe the
clinical reality of treating poisoned patients, provide
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readers with the minimal necessary clinical context,
and compare the diagnosis of a poisoned patient to
multinomial classification. We do this to explain
why we chose toxidromes as features, the errors that
are acceptable to the medical toxicologist, and the
relevant benchmarks for performance.
The diagnosis and treatment of a poisoned
patient begins with a rapid determination of
whether the patient requires immediate intervention
to prevent death. This determination is usually
made at the patient’s bedside by a physical
examination and, if the patient is conscious and
coherent, a brief discussion with the patient.
Consider a patient with progressively slowing
breathing. This raises concern for the use of, among
other things, a life-threatening opioid overdose. If
the patient’s breathing continues to slow and no
other explanation is more likely, an opioid ingestion
is assumed because the drug effect needs to be
immediately reversed to prevent death from lack of
oxygen. Opioids can slow breathing within minutes
of ingestion, but its metabolites are not detected in
urine for hours. Measuring blood concentrations of
opioids often requires specialized equipment and the
results are not available for days. Serum or urine
drug concentrations, in general, are not available
quickly enough to inform life-saving interventions.
The goal of bedside evaluation of the poisoned
patient is to identify reasons to administer
time-sensitive medications to prevent death. After
treatment, the patient is re-evaluated for a
response. The patient’s response to the intervention
guides future interventions and refinements in the
diagnosis, until the patient is stabilized. A unique
aspect of toxicology is that some treatments are
simultaneously diagnostic and therapeutic. For
example, administration of the medication naloxone
selectively reverses slowing of breathing due to
opioids (also called narcotics). If a patient responds
to naloxone, that patient’s breathing is restored and
posterior probability that an opioid caused their
respiratory has increased.
The bedside evaluation a medical toxicologist
performs resembles feature extraction and then
multinomial classification with a complex loss
function.
Table 1 displays the 6 canonical
toxidromes, the features physicians extracts from
bedside evaluation, and the feature values for
each toxidrome. The sedative-hypnotic toxidrome
is the least lethal toxidrome. Misclassifying a
sedative-hypnotic toxidrome as another is less
costly than misclassifying another toxidrome as
sedative-hypnotic. From this lens, a toxidrome is

Anticholinergic
Cholinergic
Opioid
Sedative-Hypnotic
Serotonin Toxicity
Sympathomimetic

HR BP Pup Sec Temp RR
⇑
• ⇓ ⇑
⇓
•
⇑
⇓
•
⇓
⇑
⇑

⇑
⇑

•

⇑
⇑

MS
D
S
S
S
A
⇑ A

Table 1. Six canonical toxidromes. HR, heart
rate; BP, blood pressure; Pup, pupil diameter, size
of bullet represents increased or decreased pupil
diameters; Sec, secretions; Temp, temperature; RR,
respiratory rate; MS, mental status; D, delirious,
S, sedated; A, agitated Empty cell indicates
expectation of no abnormality for that sign.
a set of ranges of values of features that define
decision regions for class membership. The word
toxidrome refers to a decision region. Toxidromes
are intended to accurately identify severe poisonings
that will respond to treatment, but may misclassify
milder poisonings.
This misclassification is
acceptable clinically because mild poisonings, in
general, do not require any specific treatment.
Some features are costly to observe or are
unobservable in some patients. A patient may
not make urine owing to kidney failure. Some
drug level concentrations are only informative at
certain intervals after ingestion, reflecting ongoing
partitioning between the bloodstream and other
parts of the body. A patient may not display
all the signs of a toxidrome. Drug effects vary
with age and prior usage.
For example, the
opioid buprenorphine (trade name Suboxone) is
more likely to slow breathing in children than
adults. The substance may not be completely
absorbed at the time of the first bedside evaluation.
A patient’s toxidrome may change over time if
the patient consumed life-threatening amounts of
many drugs with different rates of absorption
or metabolism, for example heroin and cocaine.
Genetic polymorphisms may accelerate or slow
metabolism. A patient may have taken substances
that interact with prescribed medication.
The inter-rater reliability among toxicologists in
using toxidromes to diagnose poisonings has not
been systematically studied. The need for such a
study is acknowledged[4]. The data provided here
are, to the authors’ knowledge, the first attempt to
establish such a benchmark.
The names of the toxidromes reflect the
biochemical pathways excessively activated or
blocked by classes of drugs. The anticholinergic
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toxidrome results from blockade of the acetylcholine
receptor family; cholinergic toxidrome from
activation of the acetylcholine receptor family;
opioid toxidrome from activation of the µ opioid
receptors;
sedative-hypnotic toxidrome from
activation of the GABA (γ-amino butyric acid)
receptors or blockade of glutamate receptors, and
the sympathomimetic toxidrome from activation at
adrenaline or noradrenaline receptors [5]. Serotonin
toxicity is thought to result from excess activation
at the 5-HT2A receptor[6].

1.2.

Review of Relevant Studies

network for medical diagnosis has also been
proposed but its performance not assessed [14], as
has a case-based learning approach to represent
clinical reasoning about breast cancer [15].

1.3.

Probabilistic logic networks (PLNs) aim to
represent knowledge about the world and allow
inference under uncertainty using a combination of
predicate logic, symbolic reasoning, and statistical
inference[16]. A PLN consists of a set of pairs of a
probability and a logical statement.
0.4

Machine learning techniques (e.g. Bayesian
classifiers, neural networks, decision trees) have
been applied to medical diagnosis[7].
Here
we review the application of probabilistic logic
networks that analyze text to medical diagnosis. We
exclude algorithms that use images, despite their
success in radiology and pathology. Support vector
machines have been productively applied to identify
poisonous mushrooms [8] and plants [9, 10] from
images. But, image data are often not available to
the toxicologist.
To the authors’ knowledge there have been no
prior publications on the application of probabilistic
logic networks to the diagnosis of the poisoned
patient. The Chemical Hazards and Emergency
Medical Management branch (CHEMM) of the
US Department of Health and Human Services
developed the CHEMM Intelligent Syndromes Tool.
This tool is available via a web-based interface, but
no application programming interface or scalable
endpoint is provided. There are no publications
describing its implementation, but it appears to
be based on FALCON[11], a deterministic decision
tree to co-ordinate responses against attacks with
chemical weapons.
A combination of Bayesian networks and an
ontology has been used to diagnose osteoporosis,
achieving a 72% accuracy [12]. The diagnosis
of osteoporosis is made based on the value of
one parameter, a person’s average bone density.
A person is diagnosed with osteoporosis if his
or her average bone density is 2.5σ below the
reference distribution for the general population.
Poisonings, however, are diagnosed by the presence
of overlapping categorical features. A Markov logic
network has been implemented for diagnosis of
medical conditions from Chinese-language medical
records[13], but there was no assessment of its
performance. The construction of a fuzzy Bayesian

Probabilistic Logic Networks

somnolent (x) ⇒ sedative_hypnotic (x) (1)

Equation (1) represents the concept that in
40% of possible worlds if a patient is somnolent
(excessively sleepy and lethargic) then the patient
may be poisoned by a medication from the
sedative/hypnotic class.
Software that combined rules and probabilities
was developed for medicine as early as the 1970’s,
e.g.
MYCIN[17].
Neural networks eclipsed
rule-based systems because they could operate with
inexact matching, performed more accurately, and
scaled more easily and rapidly. The adoption of
neural networks by physicians is limited, however,
owing, in part, clinicians’ reluctance to interact with
something that “doesn’t speak my language”[18].
We use ProbLog, a PLN implementation that
treats logical statements as random variables
[19]. The fraction associated with each statement
represents the fraction of words in which the logical
statement is true. The statement is assumed to
be false in all other worlds. This is sometimes
termed distributional semantics [20]. Equation 2
shows how the probability associated with a query
Q is related to the logical rules and their associated
probabilities. The sum ranges over all worlds in
which the supplied facts, F , and stated rules, R,
imply that the query Q is true. The products range
over all worlds. The first product calculates the
joint probability of the supplied facts being true.
The second product calculates the joint probability
of other facts being false. In our case, R is the set
of rules specifying the relationships between clinical
findings and toxidromes. The supplied facts, F ,
correspond to clinical findings. The query Q is for
each toxidrome. The directive is to find the query
(toxidrome) that maximizes Equation 2.

P (Q) =

X

Y

F ∪R|=Q f ∈F

p (f )

Y

1 − p (f )

(2)

f 6∈F
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Clinical Presentation

Rule-based systems need experts to create and
curate the rules as well as to adapt the rules to
include new knowledge or apply the system to
unfamiliar types of data. This need for expert
curation may limit the speed of development.
In the context of developing applications that
mimic medical thought, involving domain experts
may increase adoption. For a more complete
introduction to probabilistic logic we refer the
reader to [21] and for ProbLog to [22].
An advantage of rule-based approaches over
other machine learning approaches for medicine is
that rule-based approaches do not require large
training data sets. Many specialties within medicine
diagnose and treat rare diseases for which data sets
large enough to explore all methods of diagnosis
and treatment are unlikely to exist. Rules can be a
distillation of the received knowledge of a field, or
a combination of this distillation and relationships
inferred from large data sets, increasing model
transparency to the clinician.

1.4.

Entity Recognition

Create Query

Query PLN

Deploy PLN

Validate PLN
Compare with Ground Truth (Ideal)
Compare with Decision Tree (Benchmark)
Compare with Humans (Actual)

Create PLN
Create Logic Rules,
Assign Probabilities.

Alternative Approaches

Decision tree (DT) learning provides a
competitive alternative to PLNs. DT classifiers
can predict the risk of breast cancer[23], heart
disease[24], and diagnose diabetes[25]. DTs are
robust against collinearity. This is important in
toxicology where poisonings share overlapping
features. An elevated heart rate can be seen in
3 toxidromes (anticholinergic, sympathomimetic,
and serotonin toxicity). In 2 of those toxidromes
elevated blood pressure also occurs.
Similar to PLNs, DTs are straightforward
to understand and interpret.
It is important
that algorithms used in the care of patients
be able to explain their information processing
in ways that are explainable to and agree
with the domain-specific knowledge of physicians.
Otherwise, physicians may be less willing to
incorporate these algorithms into their medical
decision making.
DTs and PLNs require less
training data than neural networks.
This is
advantageous for medical applications, where
curated data is often tiny. All studies discussed in
Section 1.2 were developed on 150 or fewer patient
presentations.
A limitation of DTs is their tendency to overfit.
In medicine the goal of accurately diagnosing
(classifying) is often balanced against the heuristic
of recognizing a misdiagnosis (misclassification).
PLNs avoid this overfitting because they are not

Figure 1. Flowchart of project and future
directions. Dotted rectangle indicates scope of
current paper. PLN, probabilistic logic network.
Ideal (performance); Actual (performance).
trying to minimize the heterogeneity of classes.

2.

Methods

Figure 1 shows our general approach.
notation is described in more detail below.

2.1.

The

Knowledge Representation

We created 34 probabilistic logic rules based
on the consensus of three medical toxicologists.
We named these rules and the underlying
implementation in ProbLog, Tak. These rules
described the medical knowledge of the features
used to diagnose each toxidrome. We restricted
ourselves to developing rules that described
features that could be observed during one
evaluation at a patient’s bedside without laboratory
testing.
We did this to assess our approach
in the most time-sensitive aspect of medical
toxicology.
The rules were constructed as
sets of predicates as follows.
We treated
each finding elicited by the toxicologist as
a predicate.
For example, the predicate
salivation(X, increased) is true if patient
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0.10::salivation(X,decreased);
0.10::salivation(X,increased);
0.80::salivation(X,usual).
Listing 1.
Example delineation of prior
probabilities across cardinal sign with
annotated disjunction. Number preceding each
goal denotes number of worlds in which that goal is
satisfied. Numbers sum to one across values.

demonstrates increased salivation. We constructed
all predicates to have two slots, the patient and
the value of the feature, usually {present|absent}
or {increased|normal|decreased}.
These values
reflect a discretization of underlying continuous
variables, a common pattern of communication with
information compression between physicians. For
example, the respiratory rate is quantified as the
number of breaths a patient takes each minute.
Physicians, more commonly, describe a patient
as having an increased or decreased respiratory
rate, implicitly referring to an expected normal
value, rather than stating the absolute number.
We modeled medical decision making at the level
of categorical variable to reflect the nature of
communication among physicians. Anecdotally,
physicians prefer to communicate in a mix of
categorical and continuous variables, favoring
categorical variables as complexity increases.
This approach created 17 rules that describe
the prior distribution of feature values (example
in Listing 1), 10 rules that describe the posterior
probability of a toxidrome given clinical findings
(example in Listing 2), and 7 that describe the
sufficient conditions for each toxidrome (example in
Listing 3). These rules were written in ProbLog, a
Prolog extension for probabilistic logic[22].
In Listing 1, the number before the colon
represents the fraction of worlds in which
the following predicate is true.
Listing 2
demonstrates assigning the relative chance of one
toxidrome over another as a consequence of an
entity manifesting a symptom.
The function
mentalStatus(X, agitated) is true if patient X is
agitated. The function hasToxidrome(X,Y) is true
if patient X manifests toxidrome Y.
The relative probabilities across rules were
chosen to reflect the perceived relative prevalence
of each value. We used the most recent annual
report from American Association of Poison Control
Centers on the relative prevalence of each poisoning
in the US to estimate the prior probability of
each toxidrome.
Probability distributions do

4*P::hasToxidrome(X, sympathomimetic);
P::hasToxidrome(X, serotonergic) :mentalStatus(X, agitated), P is 0.2.
Listing 2. Example calculation of posterior
probability of toxidromes given value of
cardinal sign. Expression preceding each goal in
disjunction (sequence of statements separated by
semicolons) is evaluated when conditions of goal are
satisfied.
hasToxidrome(X, cholinergic) :salivation(X, increased),
urination(X, increased),
pupilDiameter(X, small).
Listing 3. Example Expression of Diagnosis of
Toxidrome as Prolog Goal.

not exist for most features.
The prevalence
of, for example, hypersalivation in the general
population is not known. Nor is it known that a
patient is exactly four times more likely to suffer
from a sympathomimetic toxidrome as opposed to
serotonin toxicity if the patient becomes agitated
after an unknown ingestion. The clinical findings
from excess serotonin activation are classically
called serotonin syndrome or serotonin toxicity, but
the term is used equivalently to a toxidrome.

2.2.

Data Set

We generated 300 simulated toxidrome
presentations following Algorithm 1 from the
list of 6 toxidromes by randomly sampling from a
uniform distribution with replacement. For each
toxidrome we created a presentation of 5 signs,
5 − k related to the toxidrome and k unrelated to
the toxidrome. The parameter k, which we term
difficulty, allows one to simulate the variability of
clinical presentation. A difficulty of 0 simulates
an unequivocal presentation. A difficulty of 2
simulates a mixed picture, as might result from
the ingestion of many substances with conflicting
effects. Table 2 shows the distribution of simulated
presentations across intended toxidromes and
difficulty. This approach mimics the early stages
of the training of a medical toxicologist, wherein
they are exposed to simple stylized cases. To the
author’s knowledge, this is the first data set created
to evaluate the inter-rater reliability of diagnosis in
medical toxicology.
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Difficulty

Anticholinergic
Cholinergic
Opioid
Sedative-Hypnotic
Serotonin Toxicity
Sympathomimetic

0

1

2

14
19
25
17
10
15

14
26
11
13
21
15

14
16
13
24
20
15

Table 2.
Distribution of Simulated
Presentations.
Algorithm 1 Generation of simulated toxidrome
Precondition: n ← 5
. Maximum number of signs per presentation
Precondition: 0 ≤ k ≤ n
. difficulty
Precondition: {t}
⇐
{sympathomimetic,
anticholinergic, cholinergic, sedative_hypnotic,
opioid, serotonin_toxicity}
. toxidromes
Precondition: {t, s, v} ⇐ {(ti , sij , vijk )}
. classic values for each sign in a toxidrome
Postcondition: {p} ⇐ {sk , vk }
. set of sign, value pairs
ti ⇐ random.choice ({t}) . intended toxidrome
t̂i ⇐ random.choice ({t} − ti ) i 6= j
. distractor toxidrome
presentation ← {}
while generated = false do
chose
(5 − k)
{s, v}
pairs
from
{(t = ti , sij , vijk )}
presentation ← pairs

chose k {s, v} pairs from { t = t̂i , sij , vijk }
presentation ← pairs
end while

toxidrome (n = 18), decreasing the number of
cases from 300 to 282. Our evaluation of actual
performance is limited by omitting these cases.
We use the term inferred toxidrome to denote the
toxidrome that Tak, the decision tree, or the human
raters inferred from the case presentation. We use
the term intended toxidrome to denote the actual
toxidrome associated with each case presentation,
i.e. the true label. The term human raters refers
to two medical toxicologists, AB and TC, who
independently reviewed each case presentation and
inferred the toxidrome. We quantified inter-rater
reliability using a multinomial extension of Cohen’s
κ. Cohen’s κ ranges between 0 and 1 where 0
indicates the level of agreement expected by chance
and 1 indicates perfect agreement.
We used the inter-rater reliability between Tak’s
inferred toxidrome and the intended toxidrome as
a measure of best performance and between Tak’s
inferred toxidrome and the consensus of the human
raters as a measure of actual performance. We took
the inter-rater reliability between the consensus of
the human raters and the generated labels as a
benchmark for actual performance.
To provide a machine learning benchmark we
trained a decision tree classifier[26] on the same
cases. We trained one decision tree classifier for each
level of difficulty. This approach is likely to lead to
overfitting, but also will overestimate the decision
tree’s performance, providing a more stringent
benchmark against which to evaluate Tak. We used
the sklearn implementation, DecisionTreeClassifier,
with the maximum depth set to 3.

3.
3.1.

2.3.

Results
Ideal Performance (Tak vs.
Intended Toxidrome)

Evaluation

We compared the performance of Tak, the
probabilistic logic network, with expert consensus,
a decision tree, and ideal performance (recovery of
the true labels generated by Algorithm 1). We
assessed actual and ideal performance by comparing
Tak’s outputs with a data set labeled by manual
curation. We presented the same cases to Tak
and human raters TC (Takuyo Chiba, M.D.)
and AB (Alexander Barbuto, M.D.), two medical
toxicologists. Tak assigned the most likely rating
to each toxidrome. TC and AB labeled each
presentation with the toxidrome they felt most
accurately described the presentation. We omitted
a presentation if either rater could not assign a

Tables 3 - 5 provide the confusion matrices
between Tak’s inferences and the intended
toxidromes.
The inter-rater reliabilities were
κ = 0.8554, κ = 0.5614, and κ = 0.2904 for
difficulty levels 0,1, and 2, respectively.
For
comparison, the inter-rater reliabilities between
the consensus of human raters and the intended
toxidromes were κ = 0.9878, κ = 0.7818, and
κ = 0.2718 for difficulty 0,1, and 2, respectively.
As the difficulty increased, the difference
between Tak’s accuracy and the human consensus
accuracy decreased. In simpler presentations, Tak
confused the sedative-hypnotic toxidrome with the
opioid toxidrome in 1/17 = 5.8% of presentations
and with the anticholinergic toxidrome in 1/17 =
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Anticholinergic
Cholinergic
Opioid
Sedative Hypnotic
Serotonin Toxicity
Sympathomimetic

7
0
0
1
0
0

κ = 0.5452
Tak
2 0 4 1
26 0 0 0
3 8 0 0
0 1 11 0
0 0 0 21
1 0 4 1

0
0
0
0
0
9

Anticholinergic
Cholinergic
Opioid
Sedative Hypnotic
Serotonin Toxicity
Sympathomimetic

0
0
0
0
0
15

Intended Toxidrome

14
0
0
1
0
0

Anticholinergic
Cholinergic
Opioid
Sedative Hypnotic
Serotonin Toxicity
Sympathomimetic

Intended Toxidrome

Anticholinergic
Cholinergic
Opioid
Sedative Hypnotic
Serotonin Toxicity
Sympathomimetic

κ = 0.8554
Intended
0 0 0 1
19 0 0 0
0 25 0 0
0 1 15 0
0 0 0 10
0 0 0

Table 3. Confusion matrix between intended
toxidromes and Tak for difficulty 0. Axis shows
rater. Axis label, mostly likely toxidrome; Number,
color in each grid, the number of diagnoses; κ
denotes Cohen’s κ.

Table 4. Confusion matrix between intended
toxidromes and Tak’s predicted toxidromes
for difficulty 1. Axis shows rater. Axis label,
mostly likely toxidrome; Number, color in each grid,
the number of diagnoses; κ denotes Cohen’s κ.

5.8% of presentations.
As difficulty increased
Tak developed difficulty distinguishing among the
anticholinergic, cholinergic, and sedative-hypnotic
toxidromes as well as between the opioid and
cholinerigc toxidromes.
These misclassification errors arise because the
features used to describe toxidromes are collinear
and features that are pairwise independent do
not have values for all toxidromes. For example,
in a poisoned patient the heart rate and blood
pressure usually move in tandem, both rising or
both falling. This collinearity is such a hallmark
of poisoned patients that its absence can prompt
medical toxicologist to consider nontoxicological
causes of the patient’s illness. The ranges of values
a feature takes on may not allow discrimination
between toxidromes. The mental status of someone
with the sympathomimetic toxidrome or serotonin
toxicity can be classified as agitated. Section 3.4
discusses this in more detail.

the confusion matrix for difficulty=0 presentations.
The decrease in inter-rater reliability for more
difficult cases arose, in part, from the introduction
of feature values that were equally predictive of
more than one toxidrome. For example, an elevated
heart rate can be a sign of the anticholinergic or
sympathomimetic toxidrome and, indeed, it can
be difficult for clinicians to distinguish these two
processes without further information. Similarly,
small pupils can be a sign of the cholinergic or opioid
toxidrome. Of the 11 cases of opioid toxidromes,
AB classified 2 as cholinergic that TC classified
as opioid. TC classified 1 as cholinergic that AB
classified as opioid. The opioid and cholinergic
toxidromes overlap clinically. Both manifest as
with constricted pupils, somnolence, and slowed
respiratory rate (confusion matrix not shown). To
the author’s knowledge this is the first published
attempt to quantify the inter-rater reliability of
medical toxicologists on any data set.

3.2.

3.3.

Usual Performance (Tak vs.
Human Consensus)

Our benchmark for usual performance was the
inter-rater reliability between the consensus of
human raters and the intended toxidromes. The
inter-rater reliability between the consensus of the
human raters and the labels predicted by Tak was
κ = 0.8432, κ = 0.4396, and κ = 0.3331, for
difficulties 0,1, and 2, respectively. Table 6 shows

Benchmark (Decision Tree vs.
Intended Toxidromes)

To compare Tak’s performance against other
machine learning approaches, we calculated the
inter-rater reliability between the ground truth
labels and a decision tree classifier.
In
straightforward presentations (difficulty, 0) Tak
outperformed the decision tree (κDT = 0.6144
vs κT ak = .8554).
In intermediate difficulty
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7
0
0
2
1
5

3.4.
2
0
2
1
2
5

Anticholinergic
Cholinergic
Opioid
Sedative Hypnotic
Serotonin Toxicity
Sympathomimetic

Intended Toxidrome

Anticholinergic
Cholinergic
Opioid
Sedative Hypnotic
Serotonin Toxicity
Sympathomimetic

κ = 0.3065
Tak
2 0 3 0
13 2 0 1
3 4 3 1
5 4 12 0
3 2 4 8
0 2 0 1

Table 5. Confusion matrix between intended
toxidromes and Tak’s predicted toxidromes
for difficulty 2. Axis shows rater. Axis label,
mostly likely toxidrome; Number, color in each grid,
the number of diagnoses; κ denotes Cohen’s κ.

Anticholinergic
Cholinergic
Opioid
Sedative Hypnotic
Serotonin Toxicity
Sympathomimetic

κ = 0.8432
Human Raters
14 0 0 0 0 0
0 18 0 0 0 0
0 2 25 3 0 0
0 0 0 4 0 2
0 0 0 0 12 0
0 0 0 0 0 15
Anticholinergic
Cholinergic
Opioid
Sedative Hypnotic
Serotonin Toxicity
Sympathomimetic

Intended Toxidrome

presentations Tak outperformed the decision tree
(κDT = 0.3527 vs κT ak = .5614).
In
complex presentations (difficulty=2) Tak performed
comparably to the decision tree (κDT = 0.2622 vs
κT ak = .2904). This benchmark was designed to
favor the decision tree. A separate decision tree was
fitted for each class of difficulty. The trees were not
averaged nor was any random forest method used.

Table 6. Confusion matrix between consensus
of human raters and predicted diagnoses for
difficulty 0. Axis shows rater. Axis label, mostly
likely toxidrome; Number, color in each grid, the
number of diagnoses; κ denotes Cohen’s κ.

Evaluation of Errors

As presentation difficulty increased Tak and
the human raters both decreased in accuracy.
This decrease in accuracy reflects the construction
of the synthetic data set and the limits of
semantic resolution of toxidromes. The synthetic
data were constructed to have three levels of
difficulty, corresponding to clinical reality. Some
patients may ingest or be exposed to a large
amount of one substance leading to an unequivocal
presentations. Others may ingest or be exposed to
many substances with a variety of stimulating and
sedating effects, the balance of which shifts over
time as the chemicals are distributed throughout
the body and metabolized at different rates.
Section 3.1 described how the features used to
discriminate toxidromes create overlapping decision
regions. The authors could find no published
analysis of the discriminative limits of toxidromes,
but it stands to reason that 6 features cannot
accurately classify into 6 categories if they are
collinear and do not have values for all categories.
Tak
confused
the
anticholinergic
and
sympathomimetic toxidromes and cholinergic,
opioid, and sedative hypnotic toxidromes. This
mimics error patterns of medical toxicologists. The
anticholinergic and sympathomimetic toxidromes
share features (increased heart rate, increased
blood pressure, and agitation). The cholinergic,
opioid, and sedative-hypnotic toxidromes share
features (sedation, and the cholinergic and opioid
toxidromes share slowed breathing and small
pupils).
Tak could distinguish serotonergic
toxicity from the anticholinergic and cholinergic
toxidromes because serotonergic toxicity has unique
features. Future work can explore the sensitivity of
classification to each rule.

4.

Conclusions

The goal of this study was to present a novel
application of using probabilistic logic to model
medical knowledge.
We derived probabilistic
logic rules from expert consensus, constructing a
probabilistic logic network, Tak. We evaluated
Tak’s performance on a synthetic data set and
compared its performance against the consensus of
domain experts and a decision tree classifier.
Figure 2 summarizes the peak, actual, and
benchmark performances. Tak’s peak and actual
performance were comparable (Ground Truth vs
Tak and (Human vs Tak). As case complexity
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Sympathomimetic

Anticholinergic
Cholinergic
Opioid
Sedative Hypnotic
Serotonin Toxicity

Intended Toxidrome

Anticholinergic
Cholinergic
Opioid
Sedative Hypnotic
Serotonin Toxicity
Sympathomimetic

κ = 0.3331
Inferred Toxidrome
5 1 3 3 0
0
0 12 3 2 0
0
0 1 7 3 0
0
0 0 0 11 0
0
0 0 0 2 11
0
1 0 0 0 2
9

Table 7. Confusion matrix between consensus
of human raters and Tak diagnoses for
difficulty 2. Axis shows rater. Axis label, mostly
likely toxidrome; Number, color in each grid, the
number of diagnoses; κ denotes Cohen’s κ.
increased Tak’s accuracy decreased, as did the
accuracy of human raters. In the most difficult
cases, Tak’s accuracy approached that of the
decision tree classifier, approximately half of human
performance. In all cases, Tak’s performance was
better than chance (κ = 0) and the decision tree,
our benchmark for current approaches.
The misclassification errors made by Tak
resemble the misclassification errors by humans,
for example confusion between the opioid
and cholinergic toxidromes and between the
sympathomimetic toxidrome and serotonin toxicity.
Tak’s performance is As it currently stands Tak’s
error rate needs improvement before clinical use.
Even if Tak never reaches accuracy comparable to
human physicians across all levels of difficulty, it
may still have a role in reducing physician error
by providing a near real-time “second opinion”
and generating a signal when Tak’s diagnosis and
the physician’s diagnosis differ. This could help
mitigate physician error due to fatigue. In addition,
Tak could be used to automate the processing of
more routine cases, freeing up physician time to
deal with more complex cases.
The most significant limitation of this paper is
that we evaluated our approach on synthetic rather
than actual clinical data. We used synthetic data
because no such clinical data set currently exists.
We took steps to generate realistic data, creating
cases at three levels of complexity to capture some
of the heterogeneity of clinical data. We reviewed

all cases with 2 medical toxicologists and excluded
18 cases they felt were not clinically plausible.
Our data set of 300 cases is not large enough to
fully
 explore the feature space, which would require
35 · 45 unique cases. Many regions of the full
feature space are not medically plausible, but their
evaluation could provide further insight into Tak.
The full value of our approach in helping physicians
treat poisoned patients will not be known until our
approach can be evaluated on actual clinical data.
For most variables empiric probability
distributions were not available. This renders
the absolute values of the calculated posterior
probabilities uninformative even if the relative
magnitude is still informative.
A limitation
of using categorical variables is that another
processing layer will be needed between entity
recognition and querying Tak to convert continuous
variables into categorical variables.
Physicians must trust an AI-based system to
include it in their evaluation and treatment of
patients. An algorithm can earn that trust through
proficiency on complex cases and transparency. Tak
demonstrates transparent clinical reasoning. This
transparency, if preserved in more accurate models,
may remove barriers to the use of AI approaches
in clinical decision making.
Even if a more
detailed analysis of the limits of PLNs suggests a
unimprovably poor performance on complex cases, a
transparent AI-system may be useful by automating
aspects routine cases and in doing so freeing up
expert time for more complicate cases.
This
is similar to the use of nurse practitioners and
physician assistants in some specialties.
The main contribution of this paper is the
demonstration that probabilistic logic networks
can model toxicologic knowledge in a way that
transparently mimics physician thought.
This
paper is also the first, to the authors’ knowledge,
to quantify the inter-rater reliability of physicians
in diagnosing poisoning. Yet another contribution
is the development of a data set that unsupervised
or weakly supervised techniques could use to explore
other knowledge representations in this domain.
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